Utah Medical Products, Inc. Announces Conclusion of FDA Inspection

SALT LAKE CITY, March 22, 2010 (GLOBE NEWSWIRE) -- Utah Medical Products, Inc. (Nasdaq:UTMD) announces that two FDA investigators have concluded a full QSIT inspection used to assess a medical device manufacturer’s compliance with the Quality System Regulation (QSR) and related regulations. The inspectional process, known as the “Quality System Inspection Technique” or QSIT, guides field investigators in conducting an efficient and effective comprehensive inspection, focusing on key elements of a firm’s quality system.

MORE ON THIS TOPIC